AIM ImmunoTech Inc. — Director's Dealing 2021

Nov 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2021-11-30

Reporting Person: LINTAL ELLEN M (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-30	Options	$1.44	A	100000	Acquired	2031-11-30	Common Stock (100000)	Direct